Monopolize FDA Inspection Data for Insurance Risk Scoring
- Organization
- Food and Drug Administration (FDA)
- Sector
- Food Safety Insurance Underwriters & Fortune 500 Retailers
- Location
- United States
Source reference
Executive summary
Current state
FDA faces a critical capacity gap where 432 investigators at 90% capacity cannot meet FSMA mandates for 19,200+ annual foreign inspections plus domestic cycles, while simultaneously failing to implement a performance management system recommended by GAO since 2015 with a July 2026 deadline approaching.
Market catalyst
FDA's fragmented public inspection databases contain complete historical violation data but lack aggregation and risk scoring - creating opportunity to build definitive private database that insurance companies desperately need for actuarial pricing and retailers need for supplier due diligence.
This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.
Field notes
Intelligence ledger
Add new evidence, corrections, or practical context to this directive. Keep claims attributable to a source where possible.
Sign in to add intelligence or vote on a field note.
Field intel logs: [ 0 ] entries. No operative updates submitted for this directive. Submit intel to claim clearance.